Compare SKYX & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKYX | CDXS |
|---|---|---|
| Founded | 2004 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 140.8M | 154.4M |
| IPO Year | 2014 | 2008 |
| Metric | SKYX | CDXS |
|---|---|---|
| Price | $0.58 | $1.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 8 |
| Target Price | $4.00 | ★ $6.14 |
| AVG Volume (30 Days) | ★ 1.1M | 845.5K |
| Earning Date | 11-12-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 11.11 | ★ 43.82 |
| EPS | ★ N/A | N/A |
| Revenue | $7,700,948.00 | ★ $138,590,000.00 |
| Revenue This Year | $13.47 | $5.02 |
| Revenue Next Year | $30.93 | $18.66 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 9.78 | ★ 32.30 |
| 52 Week Low | $0.65 | $0.90 |
| 52 Week High | $3.29 | $2.98 |
| Indicator | SKYX | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 22.39 | 47.51 |
| Support Level | N/A | $0.96 |
| Resistance Level | $1.29 | $1.29 |
| Average True Range (ATR) | 0.06 | 0.09 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 1.67 | 55.81 |
SKYX Platforms Corp operates in the business of developing proprietary technology that enables a quick and safe installation of electrical fixtures, such as light fixtures and ceiling fans. Its technology consists of a weight-bearing, fixable socket and a revolving plug for conducting electric power and supporting an electrical appliance attached to a wall or ceiling. The socket is comprised of a nonconductive body that houses conductive rings connectable to an electric power supply through terminals in its side exterior. The plug is also comprised of a nonconductive body that houses corresponding conductive rings, attaches to the socket via a male post, and is capable of feeding electric power to an appliance. It generates its income from lighting and heating products sold in the USA.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.